Hyaluronidase and trastuzumab and In-111 DTPA
Determining the interaction of Hyaluronidase and trastuzumab and In-111 DTPA and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Trastuzumab and Hyaluronidase
Generic Name: indium pentetate in-111
Brand name:
Synonyms: Pentetate Indium Disodium In 111
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronidase and trastuzumab-Inamrinone
- Hyaluronidase and trastuzumab-Inapsine
- Hyaluronidase and trastuzumab-Inatal Advance
- Hyaluronidase and trastuzumab-Inatal Ultra
- Hyaluronidase and trastuzumab-Inbrija
- Hyaluronidase and trastuzumab-Incassia
- In-111 DTPA-Hyaluronidase injection
- In-111 DTPA-Hyaluronidase Injection (Human)
- In-111 DTPA-Hyaluronidase Subcutaneous, Injection
- In-111 DTPA-Hyate:C
- In-111 DTPA-Hybrisil
- In-111 DTPA-Hycamtin